CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery disease Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial Experience With an On-Site Coronary Computed Tomography-Derived Fractional Flow Reserve Algorithm for the Assessment of Intermediate Coronary Stenoses

Review Article2018 Oct;8(5):630-646.

JOURNAL:Cardiovasc Diagn Ther. Article Link

The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short

Costa F, Valgimigli M. Keywords: DAPT duration; Dual antiplatelet therapy (DAPT); PRECISE-DAPT; bleeding; coronary stenting

FULL TEXT PDF